The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors: A Population-Based Cohort Study
Abstract
BACKGROUND: Cholinesterase inhibitors are commonly prescribed to treat dementia, but their adverse effect profile has received little attention. These drugs can provoke symptomatic bradycardia and syncope, which may lead to permanent pacemaker insertion. Drug-induced syncope may also precipitate fall-related injuries, including hip fracture. METHODS: In a population-based cohort study, we investigated the relationship between cholinesterase inhibitor use and syncope-related outcomes using health care databases from Ontario, Canada, with accrual from April 1, 2002, to March 31, 2004. We identified 19 803 community-dwelling older adults with dementia who were prescribed cholinesterase inhibitors and 61 499 controls who were not. RESULTS: Hospital visits for syncope were more frequent in people receiving cholinesterase inhibitors than in controls (31.5 vs 18.6 events per 1000 person-years; adjusted hazard ratio [HR], 1.76; 95% confidence interval [CI], 1.57-1.98). Other syncope-related events were also more common among people receiving cholinesterase inhibitors compared with controls: hospital visits for bradycardia (6.9 vs 4.4 events per 1000 person-years; HR, 1.69; 95% CI, 1.32-2.15), permanent pacemaker insertion (4.7 vs 3.3 events per 1000 person-years; HR, 1.49; 95% CI, 1.12-2.00), and hip fracture (22.4 vs 19.8 events per 1000 person-years; HR, 1.18; 95% CI, 1.04-1.34). Results were consistent in additional analyses in which subjects were either matched on their baseline comorbidity status or matched using propensity scores. CONCLUSIONS: Use of cholinesterase inhibitors is associated with increased rates of syncope, bradycardia, pacemaker insertion, and hip fracture in older adults with dementia. The risk of these previously underrecognized serious adverse events must be weighed carefully against the drugs' generally modest benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Rosenbaum, P. R., & Rubin, D. B. (1985) · The American Statistician · doi:10.2307/2683903 · Cited by 4,774
Variable Selection for Propensity Score Models
Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj149 · Cited by 2,336
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Hazards of Hospitalization of the Elderly
Creditor, M. C. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00011 · Cited by 1,409
Rivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
The epidemiology of falls and syncope
Rubenstein, L. Z., & Josephson, K. R. (2002) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00002-2 · Cited by 1,176
Austin, P. C., Grootendorst, P., & Anderson, G. M. (2007) · Statistics in Medicine · doi:10.1002/sim.2580 · Cited by 1,137
Self-citationPrevention of falls and consequent injuries in elderly people
Kannus, P., Sievänen, H., Palvanen, M., Järvinen, T., & Parkkari, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67604-0 · Cited by 1,129
(2004) · The Lancet · doi:10.1016/s0140-6736(04)16499-4 · Cited by 892
The Underrecognized Burden of Influenza in Young Children
Poehling, K. A., Edwards, K. M., Weinberg, G. A., Szilagyi, P., Staat, M. A., Iwane, M. K., Bridges, C. B., Grijalva, C. G., Zhu, Y., Bernstein, D. I., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054869 · Cited by 872
Stukel, T. A., Fisher, E. S., Wennberg, D. E., Alter, D. A., Gottlieb, D. J., & Vermeulen, M. J. (2007) · JAMA · doi:10.1001/jama.297.3.278 · Cited by 786
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752
Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary.
Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., van Dijk, J. G., Fitzpatrick, A. P., Hohnloser, S. H., Janoušek, J., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.004 · Cited by 567
When are observational studies as credible as randomised trials?
Vandenbroucke, J. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16261-2 · Cited by 538 · cited 1×
“Nonetheless, observational studies that focus on unrecognized adverse drug effects often provide credible results.(23,42) Second, we did not compare event rates for individual cholinesterase inhibitors, but the 3 drugs we studied are thought to possess similar benefits and risks.”
Background(2003) · PubMed · Cited by 490
Winblad, B., Kilander, L., Eriksson, S., Minthon, L., Båtsman, S., Wetterholm, A.-L., Jansson-Blixt, C., & Haglund, A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68350-5 · Cited by 388
The elusive pathophysiology of neurally mediated syncope
Mosqueda-Garcia, R., Furlan, R., MD, J. T., & Fernandez-Violante, R. (2000) · Circulation · doi:10.1161/01.cir.102.23.2898 · Cited by 383
Assessment and Control for Confounding by Indication in Observational Studies
Psaty, B. M., Koepsell, T. D., Lin, D., Weiss, N. S., Siscovick, D. S., Rosendaal, F. R., Pahor, M., & Furberg, C. D. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01603.x · Cited by 363
Qaseem, A., Snow, V., Cross, J. T., Forciea, M. A., Hopkins, R., Shekelle, P., Adelman, A., Mehr, D., Schellhase, K., Campos-Outcalt, D., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00008 · Cited by 354
Strickberger, S. A., Benson, D. W., Biaggioni, I., Callans, D. J., Cohen, M. I., Ellenbogen, K. A., Epstein, A. E., Friedman, P., Goldberger, J., Heidenreich, P. A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170274 · Cited by 335
Donepezil for the Treatment of Agitation in Alzheimer's Disease
Howard, R. J., Juszczak, E., Ballard, C. G., Bentham, P., Brown, R. G., Bullock, R., Burns, A. S., Holmes, C., Jacoby, R., Johnson, T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066583 · Cited by 327
Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials
Raschetti, R., Albanese, E., Vanacore, N., & Maggini, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040338 · Cited by 321
The accuracy of medicare claims data in identifying Alzheimer's disease
Taylor, D. H., Fillenbaum, G. G., & Ezell, M. E. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00452-3 · Cited by 258
A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic Drugs
Gill, S. S., Mamdani, M., Naglie, G., Streiner, D. L., Bronskill, S. E., Kopp, A., Shulman, K. I., Lee, P. E., & Rochon, P. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.808 · Cited by 234
Self-citationNeurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance
Grubb, B. P. (2005) · Circulation · doi:10.1161/circulationaha.104.482018 · Cited by 216
Guidelines on management (diagnosis and treatment) of syncope—update 2004
Brignole, M., Alboni, P., & Benditt, D. G. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.024 · Cited by 189
Psychiatric illness and mortality after hip fracture
Nightingale, S., Holmes, J., Mason, J., & House, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04421-4 · Cited by 176
Vandenbroucke, J. P., & Psaty, B. M. (2008) · JAMA · doi:10.1001/jama.2008.723 · Cited by 156
Neurocardiovascular Instability in Cognitive Impairment and Dementia
Kenny, R. A., Kalaria, R. N., & Ballard, C. G. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04816.x · Cited by 111
Urinary incontinence: an unrecognised adverse effect with donepezil
Hashimoto, M., Imamura, T., Tanimukai, S., Kazui, H., & Mori, E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02588-5 · Cited by 102
Treatment of alzheimer's disease with cholinesterase inhibitors
Schneider, L. S. S. (2001) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70072-0 · Cited by 101
Essebag, V., Hadjis, T., Platt, R. W., & Pilote, L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02709-2 · Cited by 96
Krahn, A. D., Klein, G. J., Yee, R., & Mandab, V. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70411-4 · Cited by 95
Prevalence and clinical outcomes of patients with multiple potential causes of syncope
Chen, L. Y., Gersh, B. J., Hodge, D. O., Wieling, W., Hammill, S. C., & Shen, W.-K. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.4.414 · Cited by 81
Epidemiology of syncope in hospitalized patients
Getchell, W. S., Larsen, G. C., Morris, C. D., & McAnulty, J. H. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.03199.x · Cited by 80
Representation of patients with dementia in clinical trials of donepezil.
Gill, S. S., Bronskill, S. E., Mamdani, M., Sykora, K., Li, P., Shulman, K. I., Anderson, G. M., Hillmer, M. P., Wodchis, W. P., & Rochon, P. A. (2004) · PubMed · Cited by 60
Self-citationComparison studies of cholinesterase inhibitors for Alzheimer's disease
Hogan, D. B., Goldlist, B. J., Naglie, G., & Patterson, C. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00883-x · Cited by 53
Causes of Syncope in Patients with Alzheimer???s Disease Treated with Donepezil
Bordier, P., Lanusse, S., Garrigue, S., Reynard, C., Robert, F., Gencel, L., & Lafitte, A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522080-00005 · Cited by 50
Bordier, P., Garrigue, S., Lanusse, S., Margaine, J., Robert, F., Gencel, L., & Lafitte, A. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00005 · Cited by 41
[Better reporting of harms in randomized trials: an extension of the CONSORT statement].
Gøtzsche, P. C. (2005) · PubMed · Cited by 36
Cholinesterase inhibitors and cardiovascular disease: a survey of old age psychiatrists' practice
Malone, D. M., & Lindesay, J. E. B. (2007) · Age and Ageing · doi:10.1093/ageing/afm002 · Cited by 29
Published randomized controlled trials of drug therapy for dementia often lack complete data on harm
Lee, P. E., Fischer, H. D., Rochon, P. A., Gill, S. S., Herrmann, N., Bell, C. M., Sykora, K., & Anderson, G. M. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.09.012 · Cited by 27
Self-citationThe Value of Cardiac Enzymes in Elderly Patients Presenting to the Emergency Department With Syncope
Grossman, S. A., Epp, S. V., Arnold, R., Moore, R., Lee, L., Shapiro, N. I., Wolfe, R. E., & Lipsitz, L. A. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.11.m1055 · Cited by 27
Ames, D. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006680 · Cited by 20
D’Agostino (1998) · doi:10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b
Cited by
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Current and future treatments for Alzheimer's disease
Yiannopoulou, K. G., & Papageorgiou, S. G. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612461679 · Cited by 677
Lin, J. S., O’Connor, E., Rossom, R. C., Perdue, L. A., & Eckstrom, E. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-9-201311050-00730 · Cited by 410
O’Brien, J. T., Holmes, C., Jones, M., Jones, R., Livingston, G., McKeith, I., Mittler, P., Passmore, P., Ritchie, C., Robinson, L., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116680924 · Cited by 354
Metadata
- Authors
- Gill, S. S., Anderson, G. M., Fischer, H. D., Bell, C. M., Li, P., Normand, S.-L. T., & Rochon, P. A.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2009-05-11
- Volume
- 169
- Issue
- 9
- Pages
- 867
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2079443593
- Cited by
- 306
- References
- 49
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.